I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Novel super-neutralizing antibody UT28K is capable of prote..:
Tatsuhiko Ozawa
;
Hideki Tani
;
Yuki Anraku
...
https://www.tandfonline.com/doi/10.1080/19420862.2022.2072455. , 2022
Link:
https://doi.org/10.1080/19420862.2022.2072455
RT Journal T1
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:8f1dc584acce4456861e83257e43534d&Exemplar=1&LAN=DE A1 Tatsuhiko Ozawa A1 Hideki Tani A1 Yuki Anraku A1 Shunsuke Kita A1 Emiko Igarashi A1 Yumiko Saga A1 Noriko Inasaki A1 Hitoshi Kawasuji A1 Hiroshi Yamada A1 so-Ichiro Sasaki A1 Mayu Somekawa A1 Jiei Sasaki A1 Yoshihiro Hayakawa A1 Yoshihiro Yamamoto A1 Yoshitomo Morinaga A1 Nobuyuki Kurosawa A1 Masaharu Isobe A1 Hideo Fukuhara A1 Katsumi Maenaka A1 Takao Hashiguchi A1 Hiroyuki Kishi A1 Isao Kitajima A1 Shigeru Saito A1 Hideki Niimi PB Taylor & Francis Group YR 2022 K1 COVID-19 K1 SARS-CoV-2 K1 neutralizing antibody K1 monoclonal antibody K1 super-neutralizing antibody K1 Therapeutics. Pharmacology K1 RM1-950 K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.tandfonline.com/doi/10.1080/19420862.2022.2072455 LK http://dx.doi.org/https://doi.org/10.1080/19420862.2022.2072455 DO https://doi.org/10.1080/19420862.2022.2072455 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)